Obstet Gynecol Sci.  2025 May;68(3):237-243. 10.5468/ogs.24254.

Causal association of cathepsins with female infertility: a bidirectional Mendelian randomization analysis

• Liu L
• Liao M
• Liu B
• Huang Q
• Wu H
• Li M

• KMID: 2567920
• DOI: http://doi.org/10.5468/ogs.24254

Abstract

Objective
This study aimed to systematically evaluate potential causal relationships between nine cathepsins and female infertility using Mendelian randomization (MR) methods.
Methods
A bidirectional MR analysis was conducted utilizing single nucleotide polymorphisms as instrumental variables to investigate the potential causal effects between nine cathepsins and female infertility. Genetic data on female infertility were sourced from the FinnGen study, and cathepsin-related data were obtained from genome-wide association studies datasets of European ancestry.
Results
Elevated levels of cathepsin E were significantly and inversely associated with the risk of female infertility, suggesting a potential protective role. This finding was further supported by multivariable MR analysis. However, no significant associations were observed between the other eight cathepsins and female infertility.
Conclusion
This study represents the first systematic MR analysis to identify a potential protective effect of cathepsin E on female infertility.

Keyword

Cathepsin E; Female infertility; Mendelian randomization

Reference

References

1. Cucinella G, Gullo G, Catania E, Perino A, Billone V, Marinelli S, et al. Stem cells and infertility: a review of clinical applications and legal frameworks. J Pers Med. 2024; 14:135.

2. Anyanwu M, Touray A, Kujabi T, Suwareh K, Sumbunu A, Drammeh R, et al. The prevalence and etiology of infertility in a tertiary specialist hospital in the Gambia. Glob Reprod Health. 2024; 9:e0090.

3. De Oliveira Trigo BR, Trigo A, Khan Sullivan F, Roshan D, Isazad M, Izquierdo H, et al. P-491 preliminary analysis of 943 patients using the fertility risk detection tool. Hum Reprod. 2022; 37:deac107–458.

4. Kadour-Peero E, Feferkorn I, Hadad-Liven S, Dahan MH. Does it affect the live birth rates to have a maximum endometrial thickness of 7, 8, or 9 mm in in-vitro fertilization-embryo transfer cycles? Obstet Gynecol Sci. 2024; 67:497–505.

5. Nori W, Helmi ZR. Can follicular fluid 8-oxo-2’-deoxyguanosine predict the clinical outcomes in ICSI cycle among couples with normospermia male? Obstet Gynecol Sci. 2023; 66:430–40.

6. Gallwitz L, Bleibaum F, Voss M, Schweizer M, Spengler K, Winter D, et al. Cellular depletion of major cathepsin proteases reveals their concerted activities for lysosomal proteolysis. Cell Mol Life Sci. 2024; 81:227.

7. Patel S, Homaei A, El-Seedi HR, Akhtar N. Cathepsins: proteases that are vital for survival but can also be fatal. Biomed Pharmacother. 2018; 105:526–32.

8. Cheng XW, Narisawa M, Wang H, Piao L. Overview of multifunctional cysteinyl cathepsins in atherosclerosis-based cardiovascular disease: from insights into molecular functions to clinical implications. Cell Biosci. 2023; 13:91.

9. Stoka V, Vasiljeva O, Nakanishi H, Turk V. The role of cysteine protease cathepsins B, H, C, and X/Z in neurodegenerative diseases and cancer. Int J Mol Sci. 2023; 24:15613.

10. Amjadi F, Mehdizadeh M, Ashrafi M, Nasrabadi D, Taleahmad S, Mirzaei M, et al. Distinct changes in the proteome profile of endometrial tissues in polycystic ovary syndrome compared with healthy fertile women. Reprod Biomed Online. 2018; 37:184–200.

11. Bastu E, Gokulu SG, Dural O, Yasa C, Bulgurcuoglu S, Karamustafaoglu Balci B, et al. The association between follicular fluid levels of cathepsin B, relaxin or AMH with clinical pregnancy rates in infertile patients. Eur J Obstet Gynecol Reprod Biol. 2015; 187:30–4.

12. Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023; 613:508–18.

13. Folkersen L, Fauman E, Sabater-Lleal M, Strawbridge RJ, Frånberg M, Sennblad B, et al. Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease. PLoS Genet. 2017; 13:e1006706.

14. Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, et al. Genomic atlas of the human plasma proteome. Nature. 2018; 558:73–9.

15. Pierce BL, Ahsan H, VanderWeele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011; 40:740–52.

16. Palmer TM, Lawlor DA, Harbord RM, Sheehan NA, Tobias JH, Timpson NJ, et al. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res. 2012; 21:223–42.

17. Scarcella M, d’Angelo D, Ciampa M, Tafuri S, Avallone L, Pavone LM, et al. The key role of lysosomal protease cathepsins in viral infections. Int J Mol Sci. 2022; 23:9089.

18. Abdulkhalikova D, Sustarsic A, Vrtačnik Bokal E, Jancar N, Jensterle M, Burnik Papler T. The lifestyle modifications and endometrial proteome changes of women with polycystic opvary syndrome and obesity. Front Endocrinol (Lausanne). 2022; 13:888460.

19. Scantamburlo VM, Linsingen RV, Centa LJR, Toso KFD, Scaraboto D, Araujo Júnior E,  et al. Association between decreased ovarian reserve and poor oocyte quality. Obstet Gynecol Sci. 2021; 64:532–9.

20. Song H, Zhang R, Liu Y, Wu J, Fan W, Wu J, et al. Menstrual blood-derived endometrial stem cells ameliorate ovarian senescence by relieving oxidative stress-induced inflammation. Reprod Sci. 2024; Nov. 5. [Epub]. https://link.springer.com/10.1007/s43032-024-01739-w.

21. Tanrıverdi Kılıç G, Yenigül NN, Dinçgez B, Yüce Bilgin E, Kılıç ÜK. The role of pentraxin 3 and cathepsin B levels in pregnancies complicated by preeclampsia. Biomarkers. 2024; 29:518–27.

22. Alikhani M, Amjadi F, Mirzaei M, Wu Y, Shekari F, Ashrafi M, et al. Proteome analysis of endometrial tissue from patients with PCOS reveals proteins predicted to impact the disease. Mol Biol Rep. 2020; 47:8763–74.